# Phase I/II Trial of KRN7000 in Patients With Chronic Hepatitis C Infection

> **NCT00352235** · PHASE1,PHASE2 · COMPLETED · sponsor: **Foundation for Liver Research** · enrollment: 36 (—)

## Conditions studied

- Chronic Hepatitis C

## Interventions

- **DRUG:** KRN7000

## Key facts

- **NCT ID:** NCT00352235
- **Lead sponsor:** Foundation for Liver Research
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2003-08
- **Primary completion:** —
- **Final completion:** 2005-05
- **Target enrollment:** 36 (—)
- **Last updated:** 2006-07-14

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00352235

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00352235, "Phase I/II Trial of KRN7000 in Patients With Chronic Hepatitis C Infection". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT00352235. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*